Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer
BackgroundThe lncRNAs associated with protein palmitoylation in breast cancer (BC) remain largely unexplored.MethodsWe retrieved transcriptome, proteome, and mutation data from TCGA-BRCA (BC), identified 592 palmitoylation-related lncRNAs (PRLs), const…